TTC Oncology LLC

04/29/2023

Wefunder Offering Ends This Sunday!

Dear Investors & Supporters,

Our Wefunder round is closing this Sunday, APR 30 @ 11:59 PM ET.

Though the Wefunder round is closing soon, TTC Oncology is just beginning it's journey forward — we are excited and delighted to bring you with us!

We sincerely thank each and every one of you for taking the time to learn more about how, together, we can revolutionize breast cancer treatment across the globe.

If you would like to invest further, and/or would like to share the opportunity with others, now is the time. Once this opportunity is gone, it is not likely that investors can participate further with such an incredible share structure.

For all investors, please check your Payment status by logging into Wefunder, clicking on your profile icon, and selecting "Portfolio." If you haven't finalized your funds yet, please do login and finalize your payment process.

We look forward to updating you on progress as we work to bring our Therapeutic Oral Capsule TTC-352 to market.

Thank you again for your support.

Sincerely,

The TTC Oncology Team
wefunder.com/ttc.oncology

04/21/2023

What's next? TTC Post Wefunder Plans
----
On April 10th, 2023, TTC engaged the investment banking services of Exemplar Capital, LLC. Exemplar’s mandate is to undertake a Reg D (exemption 506c) offering on behalf of TTC. TTC is seeking to raise up to $15 million to support the Company’s phase II clinical trial. TTC has also extended requests for proposals to selected CRO’s (clinical research organizations) to undertake the phase II study. Importantly, the Company has significant support from the Phase I study.

Exemplar is a highly successful New York City based investment bank, which will provide additional investor reach, credibility, and support to the TTC offering. This will be TTC's first institutional raise and management felt it best to proceed with Exemplar Capital to lead the way.

We thank Wefunder and the investment community for your steadfast support and look forward to providing future updates on our path ahead.

04/21/2023

Wefunder Round Closing Soon!

Hi Everyone,

Our Wefunder Round will be closing soon, on 4/30. If you would like to invest further, please do so now. If you haven't invested yet, now is the time! And if you have pledged an investment but have not yet setup your Payment, please do so by logging into Wefunder, clicking on your Profile icon in the upper right corner, then clicking on "Portfolio." Next to TTC Oncology, select "Finish Investment" to complete the steps, as shown below.

Now is an exciting time to invest in TTC Oncology as we are well positioned to support breast cancer patients across the globe with our revolutionary new therapy.

Thank you for your support.

Sincerely,

TTC Oncology LLC

INVEST AT: wefunder.com/ttc.oncology

03/14/2023

ONLY 2 DAYS UNTIL OUR WEBINAR!!

Join us this Thursday for a Live Webinar to learn more about TTC's Life Changing Treatment & how you can support the mission to improve lives for breast cancer patients.

To join, simply login at the following link:

https://us05web.zoom.us/j/88394424827?pwd=SGhBOWhERmJoTTZrMVA5SnB3enl5Zz09

Feel free to invite others you feel might be interested in learning more and supporting TTC's life changing drug.

03/13/2023

Words from one of our investors!

Read his full testimonial and learn more here: https://wefunder.com/ttconcology/buzz

03/11/2023

"Advancements in A.I. are beginning to deliver breakthroughs in breast cancer screening by detecting the signs that doctors miss. So far, the technology is showing an impressive ability to spot cancer at least as well as human radiologists."

Read the full article here:

https://www.nytimes.com/2023/03/05/technology/artificial-intelligence-breast-cancer-detection.html?smid=nytcore-ios-share&referringSource=articleShare

03/10/2023

This is big news that we don't want you to miss. Now more than ever, and in the years to come, TTC's ground breaking treatment can help millions of people who will be diagnosed with breast cancer.

"Advancements in A.I. are beginning to deliver breakthroughs in breast cancer screening by detecting the signs that doctors miss. So far, the technology is showing an impressive ability to spot cancer at least as well as human radiologists,"

Read the full article here:

https://www.nytimes.com/2023/03/05/technology/artificial-intelligence-breast-cancer-detection.html?smid=nytcore-ios-share&referringSource=articleShare

03/09/2023

Join us for a TTC Oncology Live Webinar to learn more about TTC's Life Changing Treatment & how you can support the mission to improve lives for breast cancer patients.

This 40m presentation includes Q&A where you can ask questions.

To join, simply login at the following link:

https://us05web.zoom.us/j/88394424827?pwd=SGhBOWhERmJoTTZrMVA5SnB3enl5Zz09

Feel free to invite others you feel might be interested in learning more and supporting TTC's life changing drug.

03/09/2023

As we celebrate women on we also need to further the fight for Breast Cancer Treatment options.

Current treatment for metastatic cancer is a frightful and dreadful experience. We have a solution but need your help. Learn more here: https://wefunder.com/ttconcology/

03/08/2023

We are excited to collaborate with Lantern Pharma to expand the clinical development of drug candidate TTC-352!

Read the the full article here:

https://finance.yahoo.com/news/lantern-pharma-ttc-oncology-establish-130000446.html?guccounter=1

DALLAS, February 27, 2023--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning ("ML") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today annou...